Determining Guidelines for Local Ambulatory Care During Flare-Ups of Mild to Moderate Ulcerative Colitis for Effective Control of the Disease at Home

Document Type : Original Article(s)

Authors

1 Assistant Professor of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Internal Medicine, School of Medicine, Integrative Functional Gastroenterology Research, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

3 Assistant Professor of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Integrative Functional Gastroenterology Research Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

4 Department of Pharmacology, School of pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran

5 Professor of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Integrative Functional Gastroenterology Research, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

10.48305/jims.v43.i812.0393

Abstract

Background: Conventionally, the treatment of ulcerative colitis flares is done on an inpatient basis due to the need for treatment with injectable drugs, but mini flare-ups treatment is generally non-injectable, and mini flare-ups of ulcerative colitis can potentially be managed on an outpatient basis and at home. Given the lack of localized clinical guidelines for managing ulcerative colitis mini flares, this study collected and synthesized expert opinions on treating mini flare-ups in outpatients and at home.
Methods: In this study, the opinions of Iranian experts were examined using a questionnaire and their opinions were summarized. The findings of the studies and the compilation of experts' opinions were used to design an outpatient care guideline for the treatment of ulcerative colitis mini-flares.
Findings: Self-care training and the level of awareness of patients are effective in controlling mini flare-ups, and the use of 5-ASA and oral and rectal corticosteroids is recommended in the treatment of mini flare-ups. Also, modifying the diet in patients was considered beneficial. In this study, the administration of probiotics and biomolecular drugs on an outpatient basis in mini flare-ups was not recommended.
Conclusion: Based on the findings of this study, the mini flare-ups treatment was recommended on an outpatient basis and at home. This recommendation requires consideration of the patient's access to medical centers and the awareness levels of both the patient and caregivers.

Highlights

Hadi Abdolahi: Google Scholar 

Mohammad Jafari: Google Scholar

Peyman Adibi: Google Scholar

Keywords

Main Subjects

References

  1. Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet 2012; 380(9853): 1606-19.
  2. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142(1): 46-54. e42.
  3. Burisch J, Pedersen N, Čuković-Čavka S, Brinar M, Kaimakliotis I, Duricova D, et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014; 63(4): 588-97.
  4. Eder P, Łodyga M, Gawron-Kiszka M, Dobrowolska A, Gonciarz M, Hartleb M, et al. Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology. Prz Gastroenterol 2023; 18(1): 1-42.
  5. Feuerstein JD, Isaacs KL, Schneider Y, Siddique SM, Falck-Ytter Y, Singh S, et al. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis. Gastroenterology 2020; 158(5): 1450-61.
  6. Nurmi E, Haapamäki J, Paavilainen E, Rantanen A, Hillilä M, Arkkila P. The burden of inflammatory bowel disease on health care utilization and quality of life. Scand J Gastroenterol 2013; 48(1): 51-7.
  7. Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis 2017; 11(6): 649-70.
  8. Marshall JK, Thabane M, Steinhart AH, Newman JR, Anand A, Irvine EJ. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2010; (1): Cd004115.
  9. Feagan BG, Macdonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2012; 10: Cd000543.
  10. Burri E, Maillard MH, Schoepfer AM, Seibold F, van Assche G, Rivière P, et al. Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update. Digestion 2020; 101(Suppl 1): 2-15.
  11. Bressler B, Marshall JK, Bernstein CN, Bitton A, Jones J, Leontiadis GI, et al. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus. Gastroenterology 2015; 148(5): 1035-58.e3.
  12. Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, et al. Ulcerative colitis. Nature Reviews Disease Primers 2020; 6(1): 74.
  13. Aslam N, Lo SW, Sikafi R, Barnes T, Segal J, Smith PJ, et al. A review of the therapeutic management of ulcerative colitis. Therap Adv Gastroenterol 2022; 15: 17562848221138160.
  14. Gros B, Kaplan GG. Ulcerative colitis in adults: A review. JAMA 2023; 330(10): 951-65.
  15. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet 2017; 389(10080): 1756-70.
  16. Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol 2019; 114(3): 384-413.
  17. Feuerstein JD, Isaacs KL, Schneider Y, Siddique SM, Falck-Ytter Y, Singh S. AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis. Gastroenterology 2020; 158(5): 1450-61.
  18. Ko CW, Singh S, Feuerstein JD, Falck-Ytter C, Falck-Ytter Y, Cross RK. AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology 2019; 156(3): 748-64.
Journal of Isfahan Medical School
Volume 43, Issue 812
4th Week, June
May and June 2025
Pages 393-400

Files

History

  • Receive Date: 20 October 2024
  • Accept Date: 01 July 2025

Share

How to cite

Statistics